Zobrazeno 1 - 10
of 1 810
pro vyhledávání: '"Chemicals and Drugs"'
Autor:
Marco Falcone, Michael Bauer, Ricard Ferrer, Gaëtan Gavazzi, Juan Gonzalez del Castillo, Alberto Pilotto, Philipp Schuetz
Publikováno v:
Scientia
Purpose Optimal treatment of infections in the elderly patients population is challenging because clinical symptoms and signs may be less specific potentially resulting in both, over- and undertreatment. Elderly patients also have a less pronounced i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::042d2c9a4fd13ec04d686ffead7f43f5
https://doi.org/10.1007/s40520-023-02388-w
https://doi.org/10.1007/s40520-023-02388-w
Autor:
Caterina Carbonell, Joan Frigola, Nuria Pardo, Ana Callejo, Patricia Iranzo, Augusto Valdivia, Ilaria Priano, Susana Cedrés, Alex Martinez‐Marti, Alejandro Navarro, Laura Lenza, Mireia Soleda, Javier Gonzalo‐Ruiz, Ana Vivancos, Miriam Sansó, Enric Carcereny, Teresa Morán, Ramon Amat, Enriqueta Felip
Publikováno v:
Scientia
Immune checkpoint inhibitors; Liquid biopsy Inhibidores del punto de control inmunitario; Biopsia líquida Inhibidors del punt de control immunitari; Biòpsia líquida Immune checkpoint inhibitors (ICIs) targeting the PD-1/PD-L1 axis are the main the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4156dbba9cbf2c8c3049073dd52fe1ee
https://doi.org/10.1002/1878-0261.13409
https://doi.org/10.1002/1878-0261.13409
Autor:
Vergote, Ignace, ray coquard, isabelle, Lorusso, Domenica, OAKNIN, ANA, Cibula, David, Van Gorp, Toon
Publikováno v:
Scientia
Recurrent cervical cancer; Combination therapy; Immunotherapy Cáncer cervical recurrente; Terapia de combinación; Inmunoterapia Càncer cervical recurrent; Teràpia combinada; Immunoteràpia Introduction: Recurrent or primary advanced metastatic ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0c8bf867c757de26684aafbb70f6c6b
https://doi.org/10.1080/13543784.2023.2179483
https://doi.org/10.1080/13543784.2023.2179483
Autor:
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla
Publikováno v:
Gut. BMJ Publishing Group
Scientia
Scientia
ObjectiveWe present the final analysis results of the phase 2 JADE study (ClinicalTrials.gov Identifier:NCT03361956).Design232 patients with chronic hepatitis B (CHB) not currently treated at study start (NCT) at study start or virologically suppress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f702b8cc4a17edfe62562c85466ffa3f
https://doi.org/10.1136/gutjnl-2022-328041
https://doi.org/10.1136/gutjnl-2022-328041
Autor:
Javier García-Corbacho, Alberto Indacochea, Azucena E. González Navarro, Iván Victoria, Débora Moreno, David Pesántez, Laura Angelats, Andrea Modrego-Sanchez, Esther Sanfeliu, Oleguer Castillo, Paula Blasco, Laura Mezquita, Nuria Viñolas, Miquel Nogué, Patricia Galván, Barbara Adamo, Neus Basté, Tamara Sauri, Manel Juan, Aleix Prat, Francesco Schettini
Publikováno v:
Scientia
Immune-checkpoint inhibitors (ICI) have revolutionized the therapeutic landscape of cancer. However, optimal patient selection is still an unmet need. One-hundred-forty-six patients with metastatic cancer candidates to ICI at the Hospital Clinic of B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c031f9d7e771faf53fb633fb85c7e5e1
https://doi.org/10.1007/s00262-022-03360-9
https://doi.org/10.1007/s00262-022-03360-9
Autor:
Evan Y. Yu, Josep M. Piulats, Gwenaelle Gravis, Peter C.C. Fong, Tilman Todenhöfer, Brigitte Laguerre, Jose A. Arranz, Stephane Oudard, Christophe Massard, Julia Heinzelbecker, Luke T. Nordquist, Joan Carles, Michael P. Kolinsky, Marinela Augustin, Howard Gurney, Ali Tafreshi, Xin Tong Li, Ping Qiu, Christian H. Poehlein, Charles Schloss, Johann S. de Bono
Publikováno v:
Scientia
Metastatic castration-resistant prostate cancer; Olaparib; Pembrolizumab Cáncer de próstata metastásico resistente a la castración; Olaparib; Pembrolizumab Càncer de pròstata metastàtic resistent a la castració; Olaparib; Pembrolizumab Backgr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca3f75fdc923eda1b2b738df1dc19c8
https://doi.org/10.1016/j.eururo.2022.08.005
https://doi.org/10.1016/j.eururo.2022.08.005
Publikováno v:
Scientia
Datos; Anticuerpos monoclonales biosimilares Dades; Anticossos monoclonals biosimilars Data; Biosimilar monoclonal antibodies Biosimilar monoclonal antibodies (mAbs) have been approved in the European Union since 2013 and have been demonstrated to re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29bcbd2dc8d6c71897439872c1e3f56d
https://doi.org/10.1002/cpt.2785
https://doi.org/10.1002/cpt.2785
Autor:
Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, Isabelle Monnet, Patricia Gomez Iranzo, Fabrizio Tabbo, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, Jose Nicolas Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, Jordi Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David James Pinato, Alessio Cortellini, Camille Leonce, Anas Gazzah, Maria-Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall’Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlesi, Enriqueta Felip, David Planchard, Benjamin Besse
Publikováno v:
Scientia
Chemotherapy; Non–small cell lung cancer; RET inhibitors Quimioteràpia; Càncer de pulmó de cèl·lules no petites; Inhibidors de RET Quimioterapia; Cáncer de pulmón de células no pequeñas; Inhibidores de RET Introduction Nearly 1% to 2% of N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f7bd4756ed222514ab170ab21d1c3d
https://doi.org/10.1016/j.jtho.2022.12.018
https://doi.org/10.1016/j.jtho.2022.12.018
Autor:
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean‐Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke, Srdan Verstovsek
Publikováno v:
Mesa, R A, Hudgens, S, Floden, L, Harrison, C N, Palmer, J, Gupta, V, McLornan, D P, McMullin, M F, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, M L, Mead, A J, Ross, D M, Oh, S T, Perkins, A, Leahy, M F, Deheshi, S, Donahue, R, Klencke, B J & Verstovsek, S 2023, ' Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies ', Cancer Medicine . https://doi.org/10.1002/cam4.5799
Scientia
Scientia
Momelotinib; Myelofibrosis; Patient-reported outcomes Momelotinib; Mielofibrosi; Resultats informats pel pacient Momelotinib; Mielofibrosis; Resultados informados por el paciente Background Myelofibrosis (MF)-associated constitutional symptoms can se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfbb9cc40d930868fce1d2a253b5f47
https://doi.org/10.1002/cam4.5799
https://doi.org/10.1002/cam4.5799
Autor:
Dolores Isla, María D. Lozano, Luis Paz-Ares, Clara Salas, Javier de Castro, Esther Conde, Enriqueta Felip, Javier Gómez-Román, Pilar Garrido, Ana Belén Enguita
Publikováno v:
Scientia
Biomarkers; Non-small cell lung cancer Biomarcadors; Carcinoma de pulmó de cèl·lules no petites Biomarcadores; Carcinomas de pulmón de células no pequeñas El carcinoma de pulmón de no célula pequeña (CPNCP) presenta el mayor número de diana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d7c9aef0e88a52fac1a02363d5f84d6
https://doi.org/10.1016/j.patol.2023.02.002
https://doi.org/10.1016/j.patol.2023.02.002